MyFinsight
Home
Blog
About
Contact
Download
Download image
Total comprehensive
loss
-$4,031,486
Total other
comprehensive income (loss)
-$7,846
Net loss
-$4,023,640
Unrealized foreign
currency translation...
-$7,846
Deemed dividend
$932,246
Net Income Loss
-$3,091,394
Gain (loss) on
extinguishment of debt, net
$14,317
Change in fair value of
warrant liability
-$593,710
Change in fair value of
derivative liabilities
$87,728
Interest income
$37
Loss before taxes
-$3,091,394
Total other income
(expense), net
$563,340
Foreign currency
transaction gain (loss)
-$19,497
Other expense
$54,000
Interest expense
$58,955
Loss from operations
-$3,654,734
Total operating
expenses
$3,654,734
Research and development
$19,961
Occupancy expenses -
related party
$6,600
Administration expenses
$3,628,173
Back
Back
Income Statement
source: myfinsight.com
Propanc Biopharma, Inc. (PPCB)
Propanc Biopharma, Inc. (PPCB)